Study In Asthma Control
Status and phase
Terminated
Phase 4
Conditions
Asthma
Treatments
Drug: salmeterol xinafoate/fluticasone propionate
Details and patient eligibility
About
This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.
Sex
All
Ages
12+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- documented clinical history of asthma and receiving regular maintenance therapy.
Exclusion criteria
- Using oral/parenteral or depot corticosteroids within 12 weeks of visit 1.
- History of heavy smoking or substance abuse.
- Females who are pregnant or lactating.
- Required emergency room treatment for their asthma 12 weeks prior to Visit 1.
- Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician.
- Other medical criteria will be evaluated at the screening visit.
Trial design
Primary purpose
Treatment
Allocation
Randomized
Interventional model
Parallel Assignment
Masking
None (Open label)
Trial contacts and locations
132
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems